US$ 23.52
tirzepatide and losartan ⚠️ New Sensory Side Effects Reported with GLP-1 Drugs, Medications like Semaglutide are widely used for Type 2 diabetes and weight loss, but recent reports suggest possible sensory ⚠️ New Sensory Side Effects
Description
GLP-1 medications prescribing trends from 20182024 reveal shifts in semaglutide and tirzepatide use for type 2 diabetes and obesity.
Experiencing dizziness on Mounjaro

These results highlight significant heterogeneity in weight trajectories following sustained exposure to a GLP-1RA therapy and identifies factors associated with increased weight loss, likely reflecting a combination of biological, behavioral, and social factors

Given the escalating cost of living, it's natural to seek ways to optimize your savings

Ready-to-Use Format
